High coverage and safety of influenza A (H1N1) 2009 monovalent vaccination among health care personnel in Thailand

被引:7
作者
Kiertiburanakul, Sasisopin [1 ]
Malathum, Kumthorn [1 ]
Watcharananan, Siriorn P. [1 ]
Bunupuradah, Pakwan [2 ]
Piebpien, Pongsathorn [2 ]
Rujiraviroj, Usa [3 ]
Likitsinsipon, Wanida [3 ]
Apivanich, Siriluk [3 ]
Kehachindawat, Pranee [3 ]
Burakitcharoen, Rungtipa [4 ]
Leelaudomlipi, Surasak [5 ,6 ]
Wananukul, Winai [1 ,6 ]
机构
[1] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Med, Bangkok 10400, Thailand
[2] Mahidol Univ, Ramathibodi Hosp, Fac Med, Clin Pharm Unit,Div Pharm, Bangkok 10400, Thailand
[3] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Nursing, Bangkok 10400, Thailand
[4] Mahidol Univ, Ramathibodi Hosp, Fac Med, Occupat Hlth Unit, Bangkok 10400, Thailand
[5] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Surg, Bangkok 10400, Thailand
[6] Mahidol Univ, Ramathibodi Hosp, Fac Med, Off Hosp Director, Bangkok 10400, Thailand
关键词
Adverse effect; H1N1; health care personnel; influenza A; Panenza; vaccine;
D O I
10.1016/j.ajic.2010.09.011
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
We aimed to report the coverage and safety of the influenza A (H1N1) 2009 monovalent vaccination (Panenza; Sanofi Pasteur, Val de Reuil Cedex, France) among health care personnel (HCP) in a university hospital setting in Thailand. The hospital set up a system to vaccinate HCP and did surveillance of the adverse effects (AEs). During a 4-week period, 6,210 (78.7%) HCP were vaccinated. There were 82 reported nonserious AEs among 32 HCP. The most common AE was fatigue/uncomfortable feeling (24%).
引用
收藏
页码:525 / 528
页数:4
相关论文
共 10 条
[1]  
Broder K., 2009, Morbidity and Mortality Weekly Report, V58, P1351
[2]  
Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400
[3]  
Harris K. M., 2010, Morbidity and Mortality Weekly Report, V59, P357
[4]   H1N1 2009 influenza among healthcare workers in a tertiary care hospital in Thailand [J].
Kiertiburanakul, S. ;
Apivanich, S. ;
Muntajit, T. ;
Sukkra, S. ;
Sirinavin, S. ;
Leelaudomlipi, S. ;
Wananukul, W. ;
Satapattayavong, B. ;
Malathum, K. .
JOURNAL OF HOSPITAL INFECTION, 2010, 74 (03) :300-302
[5]   Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial [J].
Liang, Xiao-Feng ;
Wang, Hua-Qing ;
Wang, Jun-Zhi ;
Fang, Han-Hua ;
Wu, Jiang ;
Zhu, Feng-Cai ;
Li, Rong-Cheng ;
Xia, Sheng-Li ;
Zhao, Yu-Liang ;
Li, Fang-Jun ;
Yan, Shao-Hong ;
Yin, Wei-Dong ;
An, Kang ;
Feng, Duo-Jia ;
Cui, Xuan-Lin ;
Qi, Feng-Chun ;
Ju, Chang-Jun ;
Zhang, Yu-Hui ;
Guo, Zhi-Jun ;
Chen, Ping-Yu ;
Chen, Ze ;
Yan, Kun-Ming ;
Wang, Yu .
LANCET, 2010, 375 (9708) :56-66
[6]  
Grijalva C. G., 2009, Morbidity and Mortality Weekly Report, V58, P1
[7]   A METHOD FOR ESTIMATING THE PROBABILITY OF ADVERSE DRUG-REACTIONS [J].
NARANJO, CA ;
BUSTO, U ;
SELLERS, EM ;
SANDOR, P ;
RUIZ, I ;
ROBERTS, EA ;
JANECEK, E ;
DOMECQ, C ;
GREENBLATT, DJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (02) :239-245
[8]   Emergence and pandemic potential of swine-origin H1N1 influenza virus [J].
Neumann, Gabriele ;
Noda, Takeshi ;
Kawaoka, Yoshihiro .
NATURE, 2009, 459 (7249) :931-939
[9]   Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009-10 influenza season: a multicentre, randomised controlled trial [J].
Vajo, Zoltan ;
Tamas, Ferenc ;
Sinka, Laszlo ;
Jankovics, Istvan .
LANCET, 2010, 375 (9708) :49-55
[10]  
World Health Organisation, 2009, WHO REC PAND H1N1 20